cancer clinical trials in nashville, TN
Vanderbilt University
Nashville, Tennessee 37232-6305 Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
|
Vanderbilt -Ingram Cancer Center
Nashville, Tennessee 37232 Diffuse Large B-cell Lymphoma
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Ovarian Carcinoma
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
|
Vanderbitl-Ingram Cancer Center
Nashville, Tennessee Melanoma
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Graft vs Host Disease, Cutaneous Sclerosis, Bronchiolitis Obliterans
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Rectal Cancer
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Recurrent Thyroid Cancer, Stage I Follicular Thyroid Cancer, Stage I Papillary Thyroid Cancer, Stage II Follicular Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer, Stage IVB Follicular Thyroid Cancer, Stage IVB Papillary Thyroid Cancer, Stage IVC Follicular Thyroid Cancer, Stage IVC Papillary Thyroid Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Multiple Myeloma
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Lymphoma
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
|
Nashville, Tennessee 37203-1632 Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male
|
Tennessee Oncology
Nashville, Tennessee 37203 Multiple Myeloma
|
Vanderbilt Univeristy SC
Trial Locations Vanderbilt Univeristy SC Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(4) Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Head and Neck Cancer
|
Vanderbilt University Medical Center
Nashville, Tennessee 37232-2516 Non Small Cell Lung Cancer, NSCLC
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Smoldering Multiple Myeloma
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Breast Cancer
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
|
Vanderbilt University Medical Center SC
Nashville, Tennessee 37232 Metastatic Renal Cell Carcinoma
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Childhood Cancer
|
Monroe Carrell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee 37232 Histiocytosis, Pediatric Patients With Cancer
|
Tennessee Oncology
Nashville, Tennessee 37203 Metastatic or Unresectable Solid Tumor Malignancy
|
Tennessee Oncology Dept. of Centennial Medical
Nashville, Tennessee 37203 Chronic Myelogenous Leukemia in Chronic Phase
|
Vanderbilt University Medical Center
Nashville, Tennessee 37232-2516 Fatigue, Hodgkin Lymphoma
|
Vanderbilt University Medical Center
Nashville, Tennessee 37232-2516 Cancer Survivors, Yoga
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
|
Nashville, Tennessee 37203-1632 Prostate Cancer
|
Nashville, Tennessee 37203-1632 Breast Cancer
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
|
Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2)
Nashville, Tennessee 37203 Advanced Solid Tumor, Lymphomas
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Small Cell Lung Cancer
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Advanced Solid Tumors, Metastatic Colorectal Cancer
|
Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2)
Nashville, Tennessee 37203 Solid Tumors
|
Vanderbilt University Medical Center
Nashville, Tennessee 37232-2516 Adenovirus Disease
|
Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 3
Nashville, Tennessee 37212 Acute Myeloid Leukemia (AML)
|
Nashville, Tennessee 37203-1632 Polycythemia Vera
|
Nashville, Tennessee 37203-1632 Non Squamous, Non-small-cell Lung Cancer
|
Vanderbilt-Ingram Cancer Center
Trial Locations Vanderbilt-Ingram Cancer Center Vanderbilt Cool Springs Vanderbilt Breast Center One Hundred Oaks Metastatic Breast Cancer
|
Tennessee Oncology
Nashville, Tennessee 37203 MDS, CMML, AML
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Malignant Melanoma
|
Nashville, Tennessee 37203-1632 Malignant Melanoma
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Metastatic Renal Cell Carcinoma
|
Tennessee Oncology
Nashville, Tennessee 37203 Hepatocellular Carcinoma
|
Nashville, Tennessee 37203-1632 Malignant Melanoma
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
|
Meharry Medical College
Nashville, Tennessee 37208-3599 Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Tumors Metastatic to Brain
|
Vanderbilt University
Nashville, Tennessee 37232-6305 Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma, Marginal Zone Lymphoma
|
Nashville, Tennessee 37203-1632 Lymphoma, B-Cell
|
Urology Associates, PC
Nashville, Tennessee 37209 Prostatic Neoplasms
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Advanced Solid Malignant Tumors, Advanced Ovarian Cancer
|
Nashville, Tennessee 37203-1632 Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
|
Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center
Nashville, Tennessee 37232 GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
|
Sarah Cannon Research Institute
Nashville, Tennessee 37203 Advanced Solid Tumors
|
Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 2
Nashville, Tennessee 37212 Non-small Cell Lung Cancer
|
Nashville, Tennessee 37203-1632 Metastatic Cancer, Cancer, Solid Tumors
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 Head and Neck Cancer, Precancerous Condition
|
Vanderbilt University Medical Center
Nashville, Tennessee 37232-2516 Acute Myeloid Leukemia
|
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232-6838 HER-2 Positive Breast Cancer
|
Nashville, Tennessee 37203-1632 Advanced Solid Tumors, Locally Advanced or Metastatic Breast or Colorectal Cancer
|
Vanderbilt University Medical Center
Trial Locations Vanderbilt University Medical Center Urology Associates, P.C. Advanced Prostate Cancer, Prostatic Neoplasms
|